Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

November 16, 2012

Study Completion Date

January 31, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

50 mg P005672-HCl

P005672-HCl administered as an oral capsule(s) once daily

DRUG

Placebo

Dose-matched Placebo capsule administered as an oral capsule(s) once daily

DRUG

100 mg P005672-HCl

P005672-HCl administered as an oral capsule(s) once daily

Trial Locations (38)

14609

Warner Chilcott Investigational Site, Rochester

14623

Warner Chilcott Investigational Site, Rochester

19103

Warner Chilcott Investigational Site, Philadelphia

24501

Warner Chilcott Investigational Site, Lynchburg

28144

Warner Chilcott Investigational Site, Salisbury

28209

Warner Chilcott Investigational Site, Charlotte

28401

Warner Chilcott Investigational Site, Wilmington

29650

Warner Chilcott Investigational Site, Greer

32605

Warner Chilcott Investigational Site, Gainesville

33027

Warner Chilcott Investigational Site, Miramar

33134

Warner Chilcott Investigational Site, Coral Gables

33175

Warner Chilcott Investigational Site, Miami

33761

Warner Chilcott Investigational Site, Clearwater

33781

Warner Chilcott Investigational Site, Pinellas Park

36608

Warner Chilcott Investigational Site, Mobile

40202

Warner Chilcott Investigational Site, Louisville

44532

Warner Chilcott Investigational Site, Fridley

45249

Warner Chilcott Investigational Site, Cincinnati

46256

Warner Chilcott Investigational Site, Indianapolis

46530

Warner Chilcott Investigational Site, Granger

60005

Warner Chilcott Investigational Site, Arlington Heights

60611

Warner Chilcott Investigational Site, Chicago

63117

Warner Chilcott Investigational Site, St Louis

71913

Warner Chilcott Investigational Site, Hot Springs

75093

Warner Chilcott Investigational Site, Plano

76011

Warner Chilcott Investigational Site, Arlington

77065

Warner Chilcott Investigational Site, Houston

78229

Warner Chilcott Investigational Site, San Antonio

78759

Warner Chilcott Investigational Site, Austin

84070

Warner Chilcott Investigational Site, Sandy City

85710

Warner Chilcott Investigational Site, Tucson

87106

Warner Chilcott Investigational Site, Albuquerque

90045

Warner Chilcott Investigational Site, Los Angeles

90404

Warner Chilcott Investigational Site, Santa Monica

92123

Warner Chilcott Investigational Site, San Diego

97210

Warner Chilcott Investigational Site, Portland

02135

Warner Chilcott Investigational Site, Boston

08009

Warner Chilcott Investigational Site, Berlin

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Almirall, S.A.

INDUSTRY